Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Carcinoma
|
1962 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.900 | 1.000 | 19 | 2008 | 2019 | |||||
Malignant tumor of colon
|
688 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.710 | 1.000 | 7 | 2008 | 2019 | |||||
Adenoma of large intestine
|
213 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.710 | 1.000 | 2 | 2015 | 2019 | |||||
Adenocarcinoma of large intestine
|
432 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.700 | 1.000 | 6 | 2008 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
374 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.700 | 1.000 | 6 | 2008 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
370 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.700 | 1.000 | 6 | 2008 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
373 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.700 | 1.000 | 6 | 2008 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
368 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.700 | 1.000 | 6 | 2008 | 2019 | |||||
Colorectal Neoplasms
|
609 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.700 | 1.000 | 6 | 2008 | 2019 | |||||
Malignant neoplasm of large intestine
|
375 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.700 | 1.000 | 6 | 2008 | 2019 | |||||
Nasopharyngeal carcinoma
|
320 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||
Hereditary Nonpolyposis Colorectal Cancer
|
1331 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||
Lynch Syndrome
|
65 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.020 | 1.000 | 2 | 2010 | 2015 | |||||
Alcohol or Other Drugs use
|
21 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Colon Carcinoma
|
275 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Malignant Neoplasms
|
1641 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Primary malignant neoplasm
|
1374 | 0.716 | 0.240 | 8 | 116618444 | intergenic variant | A/C | snv | 9.3E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 |